Jagsonpal Pharmaceuticals Ltd.
| BSE: 507789 | Sector: Health care |
| NSE: JAGSNPHARM | ISIN Code: INE048B01027 |
| BSE 00:00 | 01 Dec | 61.85 |
-0.85 (-1.36%) |
OPEN
62.45 |
HIGH
64.00 |
LOW
61.00 |
| NSE 00:00 | 01 Dec | 61.70 |
-0.85 (-1.36%) |
OPEN
64.10 |
HIGH
64.10 |
LOW
60.30 |
| OPEN | 62.45 |
| PREVIOUS CLOSE | 62.70 |
| VOLUME | 12545 |
| 52-Week high | 76.10 |
| 52-Week low | 16.00 |
| P/E | 15.62 |
| Mkt Cap.(Rs cr) | 162 |
| Buy Price | 61.50 |
| Buy Qty | 552.00 |
| Sell Price | 63.00 |
| Sell Qty | 25.00 |
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Sun Pharma.Inds. | 539.75 | 28.20 | 5.51 | 3211.14 |
| Dr Reddy's Labs | 4827.65 | -1.95 | -0.04 | 2937.70 |
| Cipla | 755.55 | 10.90 | 1.46 | 2318.17 |
| Aurobindo Pharma | 897.25 | 29.20 | 3.36 | 1872.74 |
| Cadila Health. | 453.45 | 3.35 | 0.74 | 1412.90 |
| Divi's Lab. | 3620.50 | 12.90 | 0.36 | 1372.71 |
| Glenmark Pharma. | 476.70 | 5.50 | 1.17 | 1354.55 |
| Alkem Lab | 2789.00 | -51.65 | -1.82 | 1264.42 |
| Alembic Pharma | 985.30 | -11.40 | -1.14 | 969.40 |
| Torrent Pharma. | 2652.55 | 41.45 | 1.59 | 938.51 |
| Gland Pharma | 2192.25 | 77.80 | 3.68 | 772.86 |
| Lupin | 909.75 | 17.95 | 2.01 | 727.55 |
| Ipca Labs. | 2276.35 | 79.50 | 3.62 | 652.46 |
| Abbott India | 15397.95 | 0.40 | 0.00 | 592.93 |
| Fortis Health. | 152.90 | 1.80 | 1.19 | 513.33 |
| Pfizer | 5105.20 | 1.10 | 0.02 | 509.13 |
| Natco Pharma | 914.00 | -7.60 | -0.82 | 474.50 |
| Apollo Hospitals | 2460.75 | 122.05 | 5.22 | 470.30 |
| Granules India | 428.60 | 16.15 | 3.92 | 444.07 |
| Ajanta Pharma | 1532.80 | -3.25 | -0.21 | 441.13 |
Quick Links for Jagsonpal Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
